glutathione cancer patients Enhanced Sonodynamic Therapy through Boosting Reactive Oxygen Species and Depleting Targeting the Vulnerability of Glutathione

Rapid blood clot removal via remote delamination and magnetization of clot debris

Published pharmacokinetic data from Aebi et al

232 Conversely, in lung and esophageal cancers, PINK1-driven mitophagy promotes proliferation and chemoresistance

In the phase 2 trial of cagrilintide 2.4 mg co-administered with semaglutide 2.4 mg (CagriSema) in people with type 2 diabetes, the combination improved glycemic control and body weight relative to semaglutide alone, consistent with amylin adding a postprandial glucose-lowering contribution on top of GLP-1 action

Selenium toxicity: a case of selenosis caused by a nutritional supplement